FORMaT: A trial investigating the best treatment for Mycobacterium abscessus infections

Details

CTAP badge
Therapeutic approach
Anti-Infective
Trial status
Open to recruitment Participating Centres
Trials Tracker ID
TT014236
Last updated
21/05/2024

Full title

FORMaT (Finding the Optimal Regimen for Mycobacterium Abscessus Treatment): A trial to find the most effective treatment for mycobacterium abscessus infections in people with CF and non- CF bronchiectasis

Study details

The aim of this study is to find the safest and most effective treatments for Mycobacterium abscessus (also called M. abscessus) infection in people with CF and non-CF bronchiectasis.

There are two groups in this study: an observation group and a treatment group.

  • The observation group will consist of people who either:
    • have only had an M. abscessus infection once or 
    • do not currently have signs of M. abscessus infection and are not currently on a treatment for M. abscessus infection.
  • The treatment group will consist of people who have a confirmed M. abscessus infection.

Participants in the observation group will be reviewed at regular visits (7 visits over 1 year). These will often coincide with routine clinic visits. Respiratory samples (such as a sputum sample) will be taken during visits. If a participant is not able to produce a sputum sample, a nebuliser containing hypertonic saline will be offered to help them to cough up phlegm.

At some visits, participants will asked to do a spirometry test (to measure lung function), a walk test and complete questionnaires.

Participants in the treatment group will be randomly assigned to different treatment plans. They will be given medications that are commonly used to treat M. abscessus infection. They will be monitored closely throughout their treatment.

As is standard practice for treating M. abscessus infections, they will undergo two phases of treatment: an intensive phase and a consolidation phase. During the intensive phase, participants will be randomly assigned to one of three treatment plans. They will have between 15 and 19 visits. For the consolidation phase, participants will again be randomly assigned to one of two treatment plans. They will have up to 10 clinic visits. 


Phase
Phase 2
Length of participation
3 years
Recruitment target
50
CF sponsor
University of Nottingham
CF sponsor type
Academic

Who can take part?

Age range
Any age
Including people

For the treatment group: 

  • People with CF of any age with a confirmed M. Abscessus infection (with imaging, positive microbiological cultures and symptoms of infection)

For the observation group:

  • Have only had a M. abscessus culture once, or
  • Do not have features of M. abscessus on lung imaging (CT scan) or symptoms of infection (for example cough, lethargy) and are not currently on a treatment for M. abscessus
     
Excluding people

For the observation group:

  • Receiving active treatment for M. Abscessus within the previous 12 months
Get in touch

CF centres running this trial

In Setup

Birmingham Children's Hospital

CTAP centre
NHS Trust
Birmingham Women's and Children's NHS Foundation Trust
Address
Steelhouse Lane
B4 6NH
Recruitment starts
Trial Coordinators
Gurcharan (Robbie) Singh
In Setup

Birmingham Heartlands Hospital (Adults)

CTAP centre
NHS Trust
University Hospitals Birmingham NHS Foundation Trust
Address
Bordesley Green
B9 5SS
Recruitment starts
Trial Coordinators
Gurcharan (Robbie) Singh
In Setup

Bristol Royal Hospital for Children

CTAP centre
NHS Trust
University Hospitals Bristol NHS Foundation Trust
Address
Upper Maudlin Street
BS2 8BJ
Recruitment starts
Trial Coordinators
Kate Alderton
In Setup

Cardiff - Noah's Ark Children's Hospital for Wales

CTAP centre
NHS Trust
Cardiff and Vale University Health Board
Address
Children and Young Adults Research Unit
Heath Park
CF14 4XW
Recruitment starts
Trial Coordinators
Catherine Joyce
In Setup

Glasgow - Queen Elizabeth University Hospital

CTAP centre
NHS Trust
NHS Greater Glasgow & Clyde
Address
1345 Govan Road
G51 4TF
Recruitment starts
Trial Coordinators
Annie Husband
In Setup

Liverpool - Alder Hey Children's Hospital

CTAP centre
NHS Trust
Alder Hey Children's NHS Foundation Trust
Address
Eaton Road
West Derby
L12 2AP
Recruitment starts
Trial Coordinators
Victoria King
In Setup

Manchester (Adults) - Wythenshawe Hospital

CTAP centre
NHS Trust
Manchester University NHS Foundation Trust
Address
Wythenshawe Hospital
South Moor Road
M23 9LT
Recruitment starts
In Setup

Royal Manchester Children's Hospital (Paediatrics)

CTAP centre
NHS Trust
Manchester University NHS Foundation Trust
Address
Oxford Road
M13 9WL
Recruitment starts
In Setup

University Hospital of Wales - Cardiff

CTAP centre
NHS Trust
Cardiff and Vale University Health Board
Address
Heath Park
CF14 4XW
Recruitment starts
Trial Coordinators
Catherine Joyce
Recruiting

Edinburgh - Royal Hospital for Children and Young People

CTAP centre
NHS Trust
NHS Lothian
Address
50 Little France Crescent
EH16 4TJ
Recruitment starts
Recruiting

Edinburgh - Western General Hospital (Adults)

CTAP centre
NHS Trust
NHS Lothian
Address
Crewe Road South
EH4 2XU
Recruitment starts
Trial Coordinators
Debbie Miller
Lynsay Houlihan
Recruiting

Nottingham Children's Hospital (Paediatrics)

CTAP centre
NHS Trust
Nottingham University Hospitals NHS Foundation Trust
Address
Queen's Medical Centre
Derby Road
NG7 2UH
Recruitment starts
Trial Coordinators
Christina Francis
Recruiting

Nottingham City Hospital (Adults)

CTAP centre
NHS Trust
Nottingham University Hospitals NHS Foundation Trust
Address
City Hospital, Wolfson Cystic Fibrosis Centre
Hucknall Road
NG5 1PB
Recruitment starts
Trial Coordinators
Fozia Naushahi
Recruiting

Southampton General Hospital

CTAP centre
NHS Trust
University Hospital Southampton NHS Foundation Trust
Address
Tremona Road
SO16 6YD
Recruitment starts
Trial Coordinators
Zoe Swash